The Drugs of Sleeping Sickness: Their Mechanisms of Action and Resistance, and a Brief History
With the incidence of sleeping sickness in decline and genuine progress being made towards the WHO goal of eliminating sleeping sickness as a major public health concern, this is a good moment to evaluate the drugs that ‘got the job done’: their development, their limitations and...
Main Author: | Harry P. De Koning |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-01-01
|
Series: | Tropical Medicine and Infectious Disease |
Subjects: | |
Online Access: | https://www.mdpi.com/2414-6366/5/1/14 |
Similar Items
-
Trypanososma brucei rhodesiense Sleeping Sickness, Uganda
by: Lea Berrang-Ford, et al.
Published: (2012-10-01) -
Chimerization at the AQP2–AQP3 locus is the genetic basis of melarsoprol–pentamidine cross-resistance in clinical Trypanosoma brucei gambiense isolates
by: Fabrice E. Graf, et al.
Published: (2015-08-01) -
APOL1 renal risk variants have contrasting resistance and susceptibility associations with African trypanosomiasis
by: Anneli Cooper, et al.
Published: (2017-05-01) -
The double-edged sword of evolution
by: Etty Kruzel-Davila, et al.
Published: (2017-07-01) -
Potent Antitrypanosomal Activities of 3-Aminosteroids against African Trypanosomes: Investigation of Cellular Effects and of Cross-Resistance with Existing Drugs
by: Charles O. Nnadi, et al.
Published: (2019-01-01)